Evidence supporting the use of: Galantamine
For the body system: Parasympathetic Nervous System

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Galantamine is a well-studied acetylcholinesterase inhibitor primarily used in the treatment of mild to moderate Alzheimer's disease. Its main mechanism of action is to inhibit the breakdown of acetylcholine, a neurotransmitter that is critical for the functioning of the parasympathetic nervous system. By increasing acetylcholine levels, galantamine enhances cholinergic transmission, which is fundamental to the rest-and-digest activities regulated by the parasympathetic nervous system. Clinical trials and meta-analyses have demonstrated that galantamine can improve cognitive function and daily living activities in patients with Alzheimer's disease, which is partially attributed to its effects on cholinergic neurotransmission. While its primary indication is for cognitive support in dementia, the underlying mechanism—acetylcholinesterase inhibition—directly impacts the parasympathetic nervous system by increasing acetylcholine availability. This can result in enhanced parasympathetic activity, as evidenced by side effects such as bradycardia, increased salivation, and gastrointestinal motility, which are mediated by the parasympathetic system. Therefore, its use to support or modulate this body system is scientifically validated, although its clinical use is generally reserved for cognitive disorders rather than direct parasympathetic support. Overall, the evidence supporting galantamine’s role in modulating the parasympathetic nervous system is robust, but its clinical application is focused on neurodegenerative conditions rather than general parasympathetic support.

More about galantamine
More about Parasympathetic Nervous System

Products containing galantamine

We currently have no products on Vitabase that contain this ingredient.